Point72 Asset Management L.P. 13D and 13G filings for Sagimet Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 7:55 pm Purchase |
2024-09-30 | 13G | Sagimet Biosciences Inc. SGMT |
Point72 Asset Management L.P. | 2,468,128 8.000% |
855,489![]() (+53.05%) |
Filing |
2024-02-05 4:34 pm Purchase |
2024-02-02 | 13G | Sagimet Biosciences Inc. SGMT |
Point72 Asset Management L.P. | 1,612,639 5.300% |
1,612,639![]() (New Position) |
Filing |